An American national survey indicates that the elevated surrogate marker of NAFLD, which is also known as serum alanine aminotransferase (ALT), is present in 8.0% among the US adolescents ageing from 12 to 19 years [13]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.